This week the New England Journal of Medicine published an expansive study using psilocybin to address treatment resistant depression. The study's authors manufactured a synthetic psilocybin (named COMP360) and gave it to participants who had not had good treatment results from at least two antidepressants...
Psychedelic Assisted Psychotherapy has made a significant introduction onto the stage of traditional therapy. Since landmark findings in the early 2000s, there has been a renewed interest in psychedelics in modern psychiatry. However, key components of the research have included integration sessions - where the...
In December 2000, Dr Rick Strassman of the University of New Mexico published DMT: The Spirit Molecule after conducting a five year government funded study examining the toxicity of the psychedelic DMT. The book, however, was not a summary of his dosage and response studies....